Investment in E.P. Medical Inc.
- Author: admin_epmed
- Category: NEWS
MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., has underwritten a Series A1 investment in E.P. Medical Co., Ltd. (Representative Director: Yuji Matsumaru; Address: 3-11-5 Nihonbashi-Honcho, Chuo-ku, Tokyo), a company developing a transcutaneous transvascular electroencephalography device to identify focal location in intractable epilepsy.
Details are attachedThis PDF (external link)Please check.
Related posts
A specific clinical study at the University of Tsukuba has been published on jRCT
Following deliberation by the Clinical Research Review Committee of the University of Tsukuba, information on specific clinical research on our…
- Category: NEWS
AMED grant recipient
Fiscal Year 2021「Medical and Engineering Collaboration Innovation Promotion Project (Development and Commercialization Project)」About the selected projects
- Category: NEWS
E.P. Medical website launched
In November 2021, the E.P. Medical website was launched.
- Category: NEWS
Series B funding from MedVenture Partners and DBJ Capital
We have raised Series B funding from MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., and…
- Category: NEWS